Study deals blow to prostate cancer prediction
This article was originally published in Clinica
Executive Summary
A paper that refutes the claim that HPC2 gene predicts a person's susceptibility to prostate cancer could prove a blow to Myriad Genetics, which is developing a test involving the gene.